CHASE PACKAGING CORP
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
WHLTStored price and day change unavailable
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2025-09-30; filed 2025-11-12.
0001477932-25-008085
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2026-03-31; filed 2026-05-15.
0001477932-26-003213
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 50 previous paragraphs and 33 current paragraphs.
21 unchanged; 11 reworded; 1 added; 11 removed; 7 previous and 0 current paragraphs rearranged.
Tables are not compared: 5 previous and 3 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (1)
Current report
Net other income (expense) was $(136,442) for the three months ended March 31, 2026, compared to net other income (expense) of $2,818 for the three months ended March 31, 2025. The change was due to the extension of the warrants’ expiration date resulting in warrants modification expense of $138,180 during the three months ended March 31, 2026 (see Note 5 to the financial statements).
Removed paragraphs (11)
Previous report
Operating expenses decreased by $2,194 for the three months ended September 30, 2025 as compared to the three months ended September 30, 2024. The decrease was related to the decrease in other general and administrative expenses offset by an increase in legal and professional fees for the three months ended September 30, 2025.
Previous report
Other income decreased by $1,564 for the nine months ended September 30, 2025 as compared to the three months ended September 30, 2024. This decrease primarily resulted from a lower bank balance during the three months ended September 30, 2025.
Previous report
For the nine months ended September 30, 2025 and 2024
Previous report
Revenue
Previous report
Operating Expenses
Previous report
Operating expenses decreased by $19,103 for the nine months ended September 30, 2025 as compared to the nine months ended September 30, 2024. The decrease was related to the decrease in legal and professional fees for the nine months ended September 30, 2025.
Previous report
Loss from Operations
Previous report
The Company incurred a loss from operations of $69,750 and $88,853 for the nine months ended September 30, 2025 and 2024, respectively.
Previous report
Other Income (Expense)
Previous report
Other income decreased by $4,234 for the nine months ended September 30, 2025 as compared to the nine months ended September 30, 2024. This decrease primarily resulted from a lower bank balance during the nine months ended September 30, 2025.
Reworded paragraphs (11)
Previous wording
Other general and administrative expenses are comprised of OTC registration fee, transfer agent and EDGAR filer services and other services. These expenses were directly related to the maintenance of the corporate entity and the preparation and filing of reports with the Securities and Exchange Commission.
Current wording
Operating expenses remained constant for the three months ended March 31, 2026 as compared to the three months ended March 31, 2025. Other general and administrative expenses are comprised of transfer agent and EDGAR filer services and other services. These expenses were directly related to the maintenance of the corporate entity and the preparation and filing of reports with the Securities and Exchange Commission.
Previous wording
The Company incurred a loss from operations of $19,969 and $22,163 for the three months ended September 30, 2025 and 2024, respectively.
Current wording
The Company incurred a loss from operations of $17,335 and $17,325 for the three months ended March 31, 2026 and 2025, respectively.
Previous wording
The Company had a net loss of $17,569 for the three months ended September 30, 2025, compared with a net loss of $18,199 for the three months ended September 30, 2024. The decrease in net loss was due to the above-mentioned effect of Other general and administrative expense.
Current wording
The Company had a net loss of $153,777 for the three months ended March 31, 2026, compared with a net loss of $14,507 for the three months ended March 31, 2025. The increase in net loss was due to the above-mentioned warrant-extension-of-expiration-date effect and to a small increase in general and administrative expenses.
Previous wording
It is anticipated that future operating expenses will decrease and then stabilize as the Company complies with its periodic reporting requirements; however, expenses may increase as the Company works to effect a business combination, although there can be no assurance that the Company will be successful in effecting a business combination.
Current wording
It is anticipated that future operating expenses will be consistent and then stabilize as the Company complies with its periodic reporting requirements; however, expenses may increase as the Company works to effect a business combination, although there can be no assurance that the Company will be successful in effecting a business combination.
Previous wording
At September 30, 2025 the Company had cash and cash equivalents of $240,748, consisting of money market funds and U.S. Treasury and government securities maturing in 3 months or less. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.
Current wording
At March 31, 2026 the Company had cash and cash equivalents of $206,369, consisting of money market funds and U.S. Treasury and government securities maturing in 3 months or less. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.
Previous wording
Net cash of $56,962 and $78,343 were used in operations during the nine months ended September 30, 2025 and 2024, respectively.
Current wording
Net cash of $15,597 and $13,679 were used in operations during the three months ended March 31, 2026 and 2025, respectively.
Previous wording
The cash used in operating activities of $78,343 for the nine months ended September 30, 2024 principally resulted from our net loss of $76,831 offset by change in accounts payable and accrued expenses of $1,512.
Current wording
The cash used in operating activities of $15,597 for the three months ended March 31, 2026 principally resulted from our net loss of $153,777 offset by change in warrants modification expense of $138,180.
Previous wording
The cash used in operating activities of $56,962 for the nine months ended September 30, 2025 principally resulted from our net loss of $61,962 offset by change in accounts payable and accrued expenses of $5,000.
Current wording
The cash used in operating activities of $13,679 for the three months ended March 31, 2025 principally resulted from our net loss of $14,507 offset by change in accounts payable and accrued expenses of $828.
Previous wording
No cash flows were used in or provided by investing activities during the nine months ended September 30, 2025 and 2024.
Current wording
No cash flows were used in or provided by investing activities during the three months ended March 31, 2026 and 2025.
Previous wording
No cash flows were used in or provided by financing activities during the nine months ended September 30, 2025 and 2024.
Current wording
No cash flows were used in or provided by financing activities during the three months ended March 31, 2026 and 2025.
Previous wording
Future earnings of the Company are dependent on interest rates earned on the Company’s invested balances and expenses incurred. The Company may incur significant expenses in connection with its objective of identifying a merger partner or acquiring an operating business.
Current wording
Future earnings of the Company are dependent on interest rates earned on the Company’s invested balances and expenses incurred. The Company expects to incur significant expenses in connection with its objective of identifying a merger partner or acquiring an operating business.
Rearranged previous paragraphs (7)
Previous report — wording carried elsewhere
The Company had no operations and no revenue for the nine months ended September 30, 2025 and 2024, and its only income was from interest income on its short-term investments which are classified as cash and cash equivalents.
Previous report — wording carried elsewhere
The following table presents our total operating expenses for the nine months ended September 30, 2025 and 2024.
Previous report — wording carried elsewhere
Other general and administrative expenses are comprised of OTC registration fee, transfer agent and EDGAR filer services and other services. These expenses were directly related to the maintenance of the corporate entity and the preparation and filing of reports with the Securities and Exchange Commission.
Previous report — wording carried elsewhere
The following table presents our total Other Income (Expense) for the nine months ended September 30, 2025 and 2024.
Previous report — wording carried elsewhere
The Company had a net loss of $61,962 for the nine months ended September 30, 2025, compared with a net loss of $76,831 for the nine months ended September 30, 2024. The decrease in net loss was due to the above-mentioned effect of legal and professional fees expense.
Previous report — wording carried elsewhere
Loss per share for the nine months ended September 30, 2025 and 2024 was approximately $(0.00) and $(0.00) based on the weighted-average shares issued and outstanding.
Previous report — wording carried elsewhere
It is anticipated that future operating expenses will decrease and then stabilize as the Company complies with its periodic reporting requirements; however, expenses may increase as the Company works to effect a business combination, although there can be no assurance that the Company will be successful in effecting a business combination.